Editor’s Note: This article is a reprint. It was originally published December 10, 2018. Omega-3 fats are essential polyunsaturated fats (PUFAs) your body needs for a wide variety of functions, including proper cell division and function of cell receptors, muscle activity, cognition and heart health. Importantly, the marine-based omega-3 fats docosahexaenoic acid (DHA) and eicosapentaenoic… Read More »
Critical to the wellbeing of pregnant women and their infants is universal screening for drug and alcohol use. This is an essential first step in identifying women with harmful substance use and connecting them with appropriate services. Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective… Read More »
In 2019, the Food and Drug Administration (FDA) approved brexanolone, marketed by Sage Therapeutics as Zulresso, as a treatment for postpartum depression (PPD). As a neurosteroid, brexanolone represents a novel approach to the treatment of postpartum mood disorders. One of the most exciting things about brexanolone is the rapidity of the response, with the initial… Read More »
According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) by reproductive-age women is on the rise. In 2003, 0.9% of women between the ages of 15 and 44 filled a prescription for an ADHD medication, compared to… Read More »
Essential Reads: ADHD in Girls and Women In childhood, ADHD is clearly more common in boys than in girls; however, in adult samples, the sex differences in prevalence are mush smaller. There is also increasing recognition that girls and women may present with a different constellation of symptoms and behaviors. For example, in children, girls… Read More »